Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carl E Allen, MD, PhD
Baylor College of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
Recruiting - Arkansas Children'S Hospital
Little Rock, Arkansas, United States
Recruiting - Children'S Hospital of Orange County
Orange, California, United States
Recruiting - Ucsf Benioff Children'S Hospital
San Francisco, California, United States
Michelle L Hermiston, MDRecruiting - Children'S National Hospital
Washington D.C., District of Columbia, United States
Recruiting - John Hopkins University School of Medicine
Baltimore, Maryland, United States
Recruiting - Dana Farber Cancer Institute, Boston Children'S
Boston, Massachusetts, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Nacho Consortium
Memphis, Tennessee, United States
Not, yet, recruiting - Children'S Medical Center- Utsw
Dallas, Texas, United States
Recruiting - Texas Children'S Hospital
Houston, Texas, United States
Recruiting - University of Wisconsin-American Family Children'S Hospital
Madison, Wisconsin, United States
Terminated
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Apr 2021
- Primary completion
- 31 Dec 2025
- Completion
- 31 Dec 2029
- Last update posted
- 18 Sept 2025
- Registered enrollment
- 90
- Registry id
- NCT04079179
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.